efsa-opinion-chromium-food-drinking-water

efsa-opinion-chromium-food-drinking-water efsa-opinion-chromium-food-drinking-water

damienvanherp
from damienvanherp More from this publisher
16.04.2014 Views

Chromium in food and bottled water Data Dose 0 0.38 0.91 2.4 5.9 Response 14/47 38/49 31/49 32/49 42/46 Models Restriction BMD Minus 10 BMDL 10 N of P- (mg/kg (mg/kg Loglikelihood Accepted parameters value b.w. per b.w. per day) day) Full model na 5 132.2 – – – – Null (reduced) model na 1 154.8 - - - - Probit na 2 142.8.2 < 10-4 no 0.56 0.43 LogProbit none 3 - - if Logistic na 2 142.8 < 10-4 no 0.53 0.39 LogLogistic none 3 - - if Quantal-Linear (QL) na 2 142.5.0 < 10-3 no 0.38 0.26 Multistage Cancer na same as QL Multistage none 3 142.5.0 < 10-4 no 0.32 0.16 Weibull none 2 - - if Gamma none 2 - - if b.w.: body weight; na: not applicable, if: invalid fit; Multistage Model, with BMR of 10% Extra Risk for the BMD and 0.95 Lower Confidence Limit for the BMDL 1 Multistage 0.9 0.8 Fraction Affected 0.7 0.6 0.5 0.4 0.3 0.2 BMDL BMD 0.1 0 1 2 3 4 5 6 dose 11:18 01/21 2014 Figure J16: Fits of the Multistage model to the dose-response data on hystiocytic cellular infiltration in the mesenteric lymph node in male mice. J 2.5. Hystiocytic cellular infiltration in mesenteric lymph nodes in female mice. For the dose-response analysis of the incidence of hystiocytic cellular infiltration in mesenteric lymph nodes in female mice three non-restricted models (log-probit, log-logistic and Weibull) showed an acceptable fit (p > 0.05) which resulted in BMDL 10 values less than 10 -5 mg/kg b.w. per day. The fit of the restricted models showed, as expected, higher BMDL 10 values (0.064 and 0.30 mg/kg b.w. per day ) than the corresponding unrestricted models but their fit was not acceptable. The graphs in Figure J17 show the fit of the log-logistic and the Weibull model, both for unrestricted and restricted modeling. EFSA Journal 2014;12(3):3595 248

Chromium in food and bottled water No BMDL 10 was determined from the dose-response data of this endpoint in female, since the BMD/BMDL ratios and the range of the BMDL values of the acceptable models are larger than one order of magnitude. Using a different modelling approach not following EFSA (2009) ADTSR (2012) reported also no BMDL. Table J17: Histiocytic cellular infiltration in mesenteric lymph nodes in female mice. The benchmark dose (BMD 10 ) and the 95 % benchmark dose lower confidence limit (BMDL 10 ) values are given for a BMR of 10 % extra risk with characteristics of the model fit. Data Dose 0 0.38 1.4 3.1 8.7 Response 3/46 29/48 26/46 40/50 42/50 Models Restriction BMD Minus 10 BMDL 10 N of P- (mg/kg (mg/kg Loglikelihood Accepted parameters value b.w. per b.w. per day) day) Full model na 5 121.8 – – – – Null (reduced) model na 1 163.0 - - - - Probit na 2 143.7 < 10 10 no 0.85 0.69 LogProbit none 3 123.8 014 yes 0.003 0.2 10-5 Logistic na 2 143.1 < 10 -10 no 0.77 0.61 LogLogistic none 3 123.8 0.13 yes 0.002 910 -7 Quantal-Linear (QL) na 2 139.2 < 10-6 no 0.41 0.30 Multistage Cancer na 1 Same as QL Multistage none 3 130.9 0.001 no 0.14 0.11 Weibull none 2 123.6 0.16 yes 0.0003 1.410 -8 Gamma none 3 - - if b.w.: body weight; na: not applicable; if: invalid fit. EFSA Journal 2014;12(3):3595 249

Chromium in <strong>food</strong> and bottled <strong>water</strong><br />

Data Dose 0 0.38 0.91 2.4 5.9<br />

Response 14/47 38/49 31/49 32/49 42/46<br />

Models<br />

Restriction<br />

BMD<br />

Minus<br />

10 BMDL 10<br />

N of<br />

P-<br />

(mg/kg (mg/kg<br />

Loglikelihood<br />

Accepted<br />

parameters<br />

value<br />

b.w. per b.w. per<br />

day) day)<br />

Full model na 5 132.2 – – – –<br />

Null (reduced) model na 1 154.8 - - - -<br />

Probit na 2 142.8.2 < 10-4 no 0.56 0.43<br />

LogProbit none 3 - - if<br />

Logistic na 2 142.8 < 10-4 no 0.53 0.39<br />

LogLogistic none 3 - - if<br />

Quantal-Linear (QL) na 2 142.5.0 < 10-3 no 0.38 0.26<br />

Multistage Cancer na same as QL<br />

Multistage none 3 142.5.0 < 10-4 no 0.32 0.16<br />

Weibull none 2 - - if<br />

Gamma none 2 - - if<br />

b.w.: body weight; na: not applicable, if: invalid fit;<br />

Multistage Model, with BMR of 10% Extra Risk for the BMD and 0.95 Lower Confidence Limit for the BMDL<br />

1<br />

Multistage<br />

0.9<br />

0.8<br />

Fraction Affected<br />

0.7<br />

0.6<br />

0.5<br />

0.4<br />

0.3<br />

0.2<br />

BMDL BMD<br />

0.1<br />

0 1 2 3 4 5 6<br />

dose<br />

11:18 01/21 2014<br />

Figure J16: Fits of the Multistage model to the dose-response data on hystiocytic cellular infiltration in<br />

the mesenteric lymph node in male mice.<br />

J 2.5.<br />

Hystiocytic cellular infiltration in mesenteric lymph nodes in female mice.<br />

For the dose-response analysis of the incidence of hystiocytic cellular infiltration in mesenteric<br />

lymph nodes in female mice three non-restricted models (log-probit, log-logistic and Weibull) showed<br />

an acceptable fit (p > 0.05) which resulted in BMDL 10 values less than 10 -5 mg/kg b.w. per day. The fit<br />

of the restricted models showed, as expected, higher BMDL 10 values (0.064 and 0.30 mg/kg b.w. per<br />

day ) than the corresponding unrestricted models but their fit was not acceptable.<br />

The graphs in Figure J17 show the fit of the log-logistic and the Weibull model, both for unrestricted<br />

and restricted modeling.<br />

EFSA Journal 2014;12(3):3595 248

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!